Patents for A61P 33 - Antiparasitic agents (21,787)
09/2003
09/18/2003WO2003075895A1 Tasted masked veterinary solid compositions
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003WO2003032928A3 Therapeutic composition and use
09/18/2003WO2002066646A3 Neurotransmission-associated proteins
09/18/2003US20030176853 Sustained release delivery systems for solutes
09/18/2003US20030176492 Having antimalarial activity against the proliferation of malarial parasites and is therefore useful as an antimalarial drug
09/18/2003US20030176466 For controlling parasites in or on an animal
09/18/2003US20030176463 For therapy of disease states resulting from angiogenesis; can be administered orally
09/18/2003US20030176453 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
09/18/2003US20030176367 Use of sublethal concentrations of anti-invasin compounds to therapeutically or prophylactically treat fungal infections
09/18/2003US20030176341 For use as an anti-viral, anti-tumour or immunomodulatory agent
09/18/2003US20030175881 Nucleic acids encoding (poly) peptides having chips activity
09/18/2003US20030175374 Oxidation resistance; anticancer agents, antiinflammatory agents; sunscreen agents
09/18/2003US20030175311 A protein encoded by DNA sequence, for protecting poultry; veterinary medicine
09/18/2003US20030175209 Image diagnosis of a brain tumor, renal carcinoma; tumor treatment therapies, immunotherapy
09/18/2003US20030175205 Comprising a radioactive materials for detecting and/or quantifying diseases or conditions associated with cancer, infections, inflammation; a 2-propane carboxylic ester with a attached phosphatidic acid group
09/18/2003CA2478846A1 Use of mixtures of lipopeptides for vaccine production
09/18/2003CA2478600A1 Antiparasitic artemisinin derivatives (endoperoxides)
09/18/2003CA2478102A1 Antigens and their use as diagnostics and vaccines against species of plasmodium
09/18/2003CA2478065A1 Macrocyclic compounds useful as pharmaceuticals
09/17/2003EP1343784A2 Urea substituted imidazoquinoline ethers
09/17/2003EP1343524A1 Vaccine based on a cellular penetration factor from an apicomplexan parasite
09/17/2003EP1183241B1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
09/17/2003EP1027359B9 Monocyclic l-nucleosides, analogs and uses thereof
09/17/2003EP0996446B1 Novel substituted imidazole compounds
09/17/2003CN1443179A Aniline derivatives
09/17/2003CN1443075A Compositions and methods for treatment of candidiasis
09/17/2003CN1121217C Immunological compound
09/17/2003CN1121214C Use of alicyclic diamines as immunomodulators
09/16/2003US6620840 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
09/16/2003US6620833 Coccidiosis treatment; 4,5-tetrafluoroethylenedioxybenzimidazole derivatives
09/16/2003US6620767 Pesticidal n-heteroaryl alpha-alkoximino-carboxamides
09/16/2003CA2054590C Novel cyclosporins
09/12/2003WO2003074543A1 Anti-protozoal vaccine
09/12/2003WO2003051333B1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
09/12/2003WO2003048371A3 Dna vaccine
09/12/2003WO2002080979A3 Conjugate of hydroxyalkyl starch and an active agent
09/12/2003WO2002058727A3 Recombinant plasmodium falciparum merozoite protein-1/42 vaccine
09/12/2003WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/12/2003WO2002056884A3 Treatment of malaria with farnesyl protein transferase inhibitors
09/11/2003US20030171424 Intravenous formulation of artelinic acid for treatment of severe and complicated malaria
09/11/2003US20030171420 Using a thiolactomycin compound as parasiticide
09/11/2003US20030171404 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
09/11/2003US20030171337 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and
09/11/2003US20030171307 Equilibrium mixture of azalide isomers, water, and one or more acids, and methods for preparing such compositions, are disclosed. The antibiotic compositions can be advantageously stabilized by adding one or more water-miscible co-solvents
09/11/2003US20030171267 Albumin fusion proteins
09/11/2003US20030170662 Screening bactericides, herbicides, malaria drugs using enzymes
09/11/2003US20030170297 Lipid-based drug delivery systems containing phospholipase a2 degradable lipid derivatives for topical application to the skin
09/11/2003US20030170257 Protecting animals against the bite of blood-sucking ectoparasites and against the transmission of viruses, bacteria and other pathogens by such ectoparasites.
09/11/2003US20030170174 For therapy of diseases, such as parasitic and viral infections, conditions associated with inflammation and infection, and conditions mediated by cell-proliferation or collagen formation; contrast agents
09/10/2003EP1341792A2 Amido ether substituted imidazoquinolines
09/10/2003EP1341791A2 Thioether substituted imidazoquinolines
09/10/2003EP1341790A2 Sulfonamido ether substituted imidazoquinolines
09/10/2003EP1341789A2 Aryl ether substituted imidazoquinolines
09/10/2003EP1341770A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
09/10/2003EP1083907B1 Control of parasitic infestations in farmed and wild fish
09/10/2003EP1035835B1 Long acting injectable formulations containing hydrogenated castor oil
09/10/2003CN1441787A Modulators of TNF-alpha signaling
09/10/2003CN1441781A Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
09/10/2003CN1441678A Compounds with sulphonamide group and pharmaceutical compositions containing these compounds
09/10/2003CN1441676A Method of treatment using ligand-immunogen conjugates
09/10/2003CN1441638A Parasiticide and parasitic method for globefish
09/10/2003CN1440973A Optical pure analog of camptothecine
09/10/2003CN1440972A Optical pure synthetic intermediate of camptothecine and its preparing method
09/10/2003CN1440816A Improvement for diagnosis and/or therapeutic agnet and its relative improvement
09/09/2003US6617441 Nucleic acid segment encoding a polypeptide of given amino acid sequence; lyme disease; flagellin and rRNA genes
09/09/2003US6617318 7-substitted tetracyclines are effective against tetracycline-resistant E. coli, S. aureus and E. faecalis strains
09/09/2003CA2183155C Naphthylisoquinoline alkaloids, pharmaceutical compositions containing them and their use for the treatment of malaria
09/04/2003WO2003073099A1 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
09/04/2003WO2003072781A1 Mite galectin
09/04/2003WO2003072725A2 Recombinant negative strand virus rna expression systems and vaccines
09/04/2003WO2003072609A1 Tick chitinase
09/04/2003WO2003072545A1 Cyclic amine compound and ccr3 inhibitory drug containing the same as active ingredient
09/04/2003WO2003072135A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
09/04/2003WO2003072113A1 Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound
09/04/2003WO2003072112A1 'long'-'acting' injectable parasiticidal composition
09/04/2003WO2003072027A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof
09/04/2003WO2003004525A8 Isolation and purification of plasmodium falciparum merozoite protein-142
09/04/2003WO2002088106A3 Cysteine protease inhibitors
09/04/2003WO2002064792A3 Molecules for disease detection and treatment
09/04/2003WO2002052002A3 Immunomodulatory polynucleotides and methods of using the same
09/04/2003WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
09/04/2003US20030166716 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases
09/04/2003US20030166671 Amorphous polymorphic forms by grinding or pulverizing; having a distinctive X-ray powder diffraction pattern; anti-tumor and -carcinogenic agents; administered by mouth, intravenous injection and inhalation
09/04/2003US20030166634 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists
09/04/2003US20030166630 Amino acid derivatives and their use as medicines
09/04/2003US20030166613 A macrocyclic diterpene plant extract for treating viral infections; A computer program product for storing the library information of candidate compounds
09/04/2003US20030166556 Immunoregulator
09/04/2003US20030166530 Conjugate heat shock protein-binding peptides
09/04/2003US20030166277 Targeted vaccine delivery systems
09/04/2003US20030166229 Human POSH-like protein 1
09/04/2003US20030166165 Comprises nucleotide sequences coding polyene macrolide antibiotics for use in veterinary medicine
09/04/2003US20030165872 Comprises nucleotide sequences coding protozoan parasite protein for diagnosis and prevention of infections; veterinary medicine; miticides; parasiticides; dog vaccine
09/04/2003US20030165529 Vaccine against tyrpanosomiasis
09/04/2003US20030165478 Stabilized synthetic immunogen delivery system
09/04/2003US20030165460 Proteins which control cell differentiation; immunology response; antiinflammatory agents; wound healing agents
09/04/2003CA2477037A1 Recombinant negative strand virus rna expression systems and vaccines
09/04/2003CA2476896A1 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
09/04/2003CA2476630A1 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof